Peter L. Salgo, MD: Before we use a very broad brush, which we’ve been doing, to discuss multiple sclerosis [MS], we’ve been able to get the subgroups and subtypes, right? There are different kinds of ...

Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...

Tumefactive multiple sclerosis (MS) is a rare type of MS that causes a tumor-like lesion in your brain. This lesion can press on nearby parts of your brain, leading to many symptoms. Multiple ...

Professional societies of neurologists, including most prominently the American Academy of Neurology (AAN) and the European Academy of Neurology (EAN) periodically release recommendations to guide ...

What Is Late-Onset Multiple Sclerosis? When you have multiple sclerosis (MS), your immune system attacks nerve cells and fibers called axons in your brain. When this happens, your brain can’t send ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

Janelle McSwiggin is a registered nurse with five years of bedside experience supporting public health measures in her community. Janelle has been a writer and editor for social media content, ...